Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of age

Archives of Disease in Childhood

Volumn 99, Issue 7, 2014, Pages 687-693

  Lassi, Zohra S ^a   Das, Jai K ^a   Haider, Syed Waqas ^a   Salam, Rehana A ^a   Qazi, Shamim A ^b   Bhutta, Zulfiqar A ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; GENTAMICIN; PENICILLIN G; AZITHROMYCIN; BENZATHINE PENICILLIN; LEVOFLOXACIN; PENICILLIN DERIVATIVE; PROCAINE PENICILLIN;

ANTIBIOTIC THERAPY; CHILDHOOD MORTALITY; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; DRUG TREATMENT FAILURE; GROUPS BY AGE; HUMAN; LOWEST INCOME GROUP; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOUTHEAST ASIA; SYSTEMATIC REVIEW; TREATMENT DURATION; WORLD HEALTH ORGANIZATION; CHILDHOOD DISEASE; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; HEALTH CARE COST; MORTALITY; PNEUMONIA; RECOMMENDED DRUG DOSE; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; INFANT; PNEUMONIA; TREATMENT OUTCOME;

EID: 84902380153     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2013-304023     Document Type: Review

References (63)

1. Walker CL, Rudan I, Liu L, et al. Global burden of childhood pneumonia and diarrhoea. Lancet 2013;381:1405-16.
2. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-128.
3. Ostapchuk M, Roberts DM, Haddy R. Community-acquired pneumonia in infants and children. Am Fam Physician 2004;70:899-908. (Pubitemid 39201441)
4. WHO. Pneumonia fact sheet. Geneva, Switzerland: World Health Organization, 2013. http://www.who.int/mediacentre/factsheets/fs331/en/ (accessed 13 Jul 2013).
5. Lodha R, Kabra SK, Pandey RM. Antibiotics for community-acquired pneumonia in children. Cochrane Database Syst Rev 2013;(6):CD004874.
6. Rojas MX, Granados C. Oral antibiotics versus parenteral antibiotics for severe pneumonia in children. Cochrane Database Syst Rev 2006;(2):CD004979.
7. Lassi ZS, Haider BA, Bhutta ZA. Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes. Cochrane Database Syst Rev 2010;(11):CD007754.
8. Haider BA, Lassi ZS, Bhutta ZA. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev 2008;(2):CD005976.
9. WHO, UNICEF. IMCI chart booklet - standard. Geneva: World Health Organization, 2008.
10. WHO. Integrated management of Childhood illnesses. Geneva: Department of Child and Adolescent Health and Development (CAH), World Health Organization; 2008. Available at: whqlibdoc.who.int/publications/2008/9789241597289-eng.pdf (accessed 13 Dec 2013).
11. WHO. WHO programme for the control of acute respiratory infections: technical bases for the WHO recommendations on the management of pneumonia in children at first level facilities. Geneva, Switzerland: World Health Organization, 1991.
12. American Academy of Paediatrics. Report of the Committee on infectious diseases. Pneumococcal infections. Elk Grove Village, Illinois: Red Book American Academy of Paediatrics; 2000, 457 ISBN No 1080-0131.
13. WHO. Management of children with pneumonia and HIV in low-resource settings. Report of a consultative meeting. Zimbabwe, January 2003. http://whqlibdoc.who.int/publications/2004/9241591285.pdf (accessed 13 Jul 2013).
14. WHO Expert Committee. The selection and use of essential medications. WHO Technical Report Series 958. Geneva: World Health Organization, 2009.
15. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (Rev Man). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
16. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org
17. Asghar R, Banajeh S, Egas J, et al. Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study). Br Med J 2008;336:80-4.
18. Duke T, Poka H, Dale F, et al. Chloramphenicol versus benzylpenicillin and gentamicin for the treatment of severe pneumonia in children in Papua New Guinea: a randomised trial. Lancet 2002;359:474-80. (Pubitemid 34164294)
19. Bansal A, Singhi SC, Jayashree M. Penicillin and gentamicin therapy vs amoxicillin/clavulanate in severe hypoxemic pneumonia. Indian J Pediatr 2006;73:305-9. (Pubitemid 44326187)
20. Ribeiro CF, Ferrari GF, Fioretto JR. Antibiotic treatment schemes for very severe community-acquired pneumonia in children: a randomized clinical study. Pan Am J Pub Health 2011;6:444-50.
21. Cetinkaya F, Gogremis A, Kutluk G. Comparison of two antibiotic regimens in the empirical treatment of severe childhood pneumonia. Indian J Pediatr 2004;71:969-72. (Pubitemid 40029834)
22. Straus WL, Qazi SA, Kundi Z, et al. Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxicillin for pneumonia among children in Pakistan: randomised controlled trial. Lancet 1998;352:270-4. (Pubitemid 28340144)
23. Addo-Yobo E, Chisaka N, Hassan M, et al. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study. Lancet 2004;364:1141-8. (Pubitemid 39296601)
24. Hazir T, Fox LAM, Nisar YB, et al. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial. Lancet 2008;371:49-56.
25. Atkinson M, Lakhanpaul M, Smyth A, et al. Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial. Thorax 2007;62:1102-06. (Pubitemid 350206206)
26. Campbell H, Forgie IM, Lloyd-Evans N, et al. Trial of co-trimoxazole versus procaine penicillin with ampicillin in treatment of community-acquired pneumonia in young Gambian children. Lancet 1988;332:1182-4. (Pubitemid 18267012)
27. Peltola H, Vuori-Holopainen E, Kallio MJ. Successful shortening from seven to four days of parenteral beta-lactam treatment for common childhood infections: a prospective and randomized study. Int J Infect Dis 2001;5:3-8. (Pubitemid 32319020)
28. Shann F, Barker J, Poore P. Chloramphenicol alone versus chloramphenicol plus penicillin for severe pneumonia in children. Lancet 1985;2:684-6.
29. Mulholland EK, Falade AG, Corrah PT, et al. A randomized trial of chloramphenicol vs trimethoprim sulfamethoxazole for the treatment of malnourished children with community acquired pneumonia. Pediatr Infect Dis J 1995; 14:959-65.
30. Nogeova A, Galova K, Krizan L, et al. Ceftibuten vs. cefuroxime-axetil in initial therapy for community-acquired bronchopneumonia: randomized multicentric study in 140 children. Infect Dis Clin Pract 1997;6:133-4. (Pubitemid 27145349)
31. Klein M; The International Study Group. Multicenter trial of cefpodoxime proxetil vs. amoxicillin-clavulanate in acute lower respiratory tract infections in childhood. Pediatr Infect Dis J 1995;14(Suppl):19-22.
32. CATCHUP. Clinical efficacy of co-trimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in Pakistan. Arch Dis Child 2002;86:113-18.
33. Awasthi S, Agarwal G, Singh JV, et al. Effectiveness of 3-day amoxicillin vs. 5-day co-trimoxazole in the treatment of non-severe pneumonia in children aged 2-59 months of age: a multi-centric open labeled trial. J Trop Pediatr 2008;54:382-9.
34. Bradley JS, Arguedas A, Blumer JL, et al. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia. Pediatr Infect Dis J 2007;26:868-78. (Pubitemid 47494158)
35. Harris JA, Kolokathis A, Campbell M, et al. Safety and ef ficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J 1998;17:865-71. (Pubitemid 28506406)
36. Wubbel L, Muniz L, Ahmed A. et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J 1999;18:98-104. (Pubitemid 29101880)
37. Keeley DJ, Nkrumah FK, Kapuyanyika C. Randomized trial of sulfamethoxazole+ trimethoprim versus procaine penicillin for the outpatient treatment of childhood pneumonia in Zimbabwe. Bull World Health Organ 1990;68:185-92. (Pubitemid 20190056)
38. Deivanayagam N, Nedunchelian K, Ashok TP, et al. Effectiveness of ampicillin and combination of penicillin and chloramphenicol in the treatment of pneumonias: randomized controlled trial. Indian Pediatr 1996;33:813-16. (Pubitemid 26370227)
39. Camargos PAM, Guimaraes MDC, Ferreira CS. Benzathine penicillin for unilateral lobar or segmental infiltrates presumptively caused by Streptococcus pneumoniae in children 2-12 years old. J Trop Pediatr 1997;43:353-60. (Pubitemid 28040676)
40. Rasmussen ZA, Bari A, Qazi S, et al. Randomized controlled trial of standard versus double dose cotrimoxazole for childhood pneumonia in Pakistan. Bull World Health Organ 2005;83:10-19.
41. Fonseca W, Hoppu K, Rey LC, et al. Comparing pharmacokinetics of amoxicillin given twice or three times per day to children older than 3 months with pneumonia. Antimicrob Agents Chemother 2003;47:997-1001. (Pubitemid 36254226)
42. Daschner FD, Behre U, Dalhoff A. Prospective clinical trial on the efficacy of amoxicillin administered twice or four times daily in children with respiratory tract infections. J Int Med Res 1981;9:274-6. (Pubitemid 12247987)
43. Cook RC, Zachariah J, Cree F, et al. Efficacy of twice-daily amoxicillin/clavulanate ('Augmentin-Duo' 400/57) in mild to moderate lower respiratory tract infection in children. Br J Clin Pract 1996;50:125-8. (Pubitemid 26130611)
44. Kartasasmita C, Saha S; Short Course Cotrimoxazole Study Group. Three days versus five days oral cotrimoxazole for non-severe pneumonia. Paper presented at: consultative meeting to review evidence and research priorities in the management of acute respiratory infections (ARI). Geneva: Department of Child and Adolescent Health and Development, World Health Organization meeting report, 2003. Sep 29-Oct 1.
45. Lupisan SP, Medalla FM, Miguel CA, et al. A randomized, placebo controlled clinical trial of short course cotrimoxazole for the treatment of pneumonia in filipino children. Phil J Microbiol Infect Dis 1999;28:15-20.
46. MASCOT. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet 2002;360:835-41.
47. ISCAP Study Group. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. Br Med J 2004;328:791.
48. Ficnar B, Huzjak N, Oreskovic K, et al. Azithromycin: 3-day versus 5-day course in the treatment of respiratory tract infections in children. J Chemother 1997;9:38-43. (Pubitemid 27127987)
49. Tsarouhas N, Shaw KN, Hodinka RL, et al. Effectiveness of intramuscular penicillin versus oral amoxicillin in the early treatment of outpatient pediatric pneumonia. Pediatr Emerg Care 1998;14:338-41. (Pubitemid 28498709)
50. Sidal M, Oguz F, Unuvar A, et al. Trial of co-trimoxazole versus procaine penicillin G and benzathin penicillin + procaine penicillin G in the treatment of childhood pneumonia. J Trop Pediatr 1994;40:301-4. (Pubitemid 24322674)
51. Jibril HB, Ifere OA, Odumah DU. An open, comparative evaluation of amoxicillin and amoxicillin plus clavulanic acid ('Augmentin') in the treatment of bacterial pneumonia in children. Curr Med Res Opin 1989;11:585-92. (Pubitemid 20009450)
52. Hazir T, Nisar YB, Abbasi S, et al. Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2-59 months: a multicenter, double-blind, randomized, placebo-controlled trial in Pakistan. Clin Infect Dis 2010;52:293-300.
53. Block S, Hedrick J, Hammerschlag MR, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J 1995;14:471-7.
54. Aurangzeb B, Hameed A. Comparative efficacy of amoxicillin, cefuroxime and clarithromycin in the treatment of community acquired pneumonia in children. J Coll Physicians Surg Pak 2003;13:704-7. (Pubitemid 38181157)
55. Roord JJ, Wolf BH, Gossens MM, et al. Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections. Antimicrob Agents Chemother 1996;40:2765-8. (Pubitemid 26404340)
56. Kogan R, Martínez MA, Rubilar L, et al. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children. Pediatr Pulmonol 2003;35:91-8. (Pubitemid 36177102)
57. Ferwerda A, Moll HA, Hop WCJ, et al. Efficacy, safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections. J Antimicrob Chemother 2001;47:441-6. (Pubitemid 32303410)
58. WHO. Pocket book of hospital care for children. Guidelines for the management of common illnesses with limited resources. 2005. Geneva, WHO. Available at: http://www.who.int/maternal-child-adolescent/documents/9241546700/ en/ (accessed 13 Dec 2013).
59. Punpanich W, Groome M, Muhe L, et al. Antibiotic and systemic therapies for pneumonia in human immunodeficiency virus (HIV)-infected and HIV-exposed children. J Infect Dev Ctries 2012;6:109-19.
60. American Academy of Paediatrics. Report of the Committee on infectious diseases. Pneumococcal infections. Elk Grove Village, Illinois: Red Book American Academy of Paediatrics: 200:p457. ISBN No 1080-0131.
61. Dagan R, McCracken GH Jr. Flaws in design and conduct of clinical trials in acute otitis media. Pediatr Infect Dis J 2002, 21:894-902. (Pubitemid 35176147)
62. Duke T, Wandi F, Jonathan M, et al. improved oxygen systems for childhood pneumonia: a multihospital effectiveness study in papua new guinea. Lancet 2008;372:1328-33.
63. Bhutta ZA, Das JK, Walker N, et al. Lancet Diarrhoea and Pneumonia Interventions Study Group. Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? Lancet 2013;381:1417-29.